AEHR Stock 2026: Buy or Sell? SiC Recovery Outlook

For informational purposes only. Not personalized investment advice. Published: June 2025. Last updated: June 2025.

If you found this page searching for AEHRUSDT, you are in the right place. The USDT suffix comes from cryptocurrency trading pair notation used on platforms like TradingView, where equity tickers sometimes appear alongside crypto pairs. AEHR is not a cryptocurrency. Aehr Test Systems (NASDAQ: AEHR) is a publicly traded US semiconductor equipment company, and this article is a traditional equity analysis.

The stock ran from roughly $3 per share in 2021 to nearly $53 in mid-2023, then fell more than 80% to the single-digit range where it trades today. Whether 2026 marks the beginning of a recovery depends on one question: is the silicon carbide semiconductor market coming back?

TLDR: AEHR 2026 Quick Summary

• What is AEHRUSDT? A search notation, not a crypto asset. AEHR is a NASDAQ-listed semiconductor equipment stock.
• Current price: As of June 2025, AEHR trades in the $5–$8 range (verify current price at the Aehr Test Systems investor relations page).
• Base case 2026 price target: $12–$15, assuming SiC demand normalization begins in H2 2025 and a 3–4x P/S multiple on projected FY2026 revenue of approximately $60–$70M.
• Verdict: Speculative Buy for investors with high risk tolerance and a 12–24 month horizon, conditional on SiC recovery materializing.
• Thesis: AEHR's wafer-level burn-in technology is still required by SiC manufacturers. The revenue collapse is cyclical, not structural, but recovery timing is uncertain.

For live AEHR stock price data, see Aehr Test Systems Stock Price Today: Live AEHRUSDT Data. For analyst consensus price targets, see AEHR Stock Forecast 2026: Analyst Price Targets.

What Is Aehr Test Systems? Company Overview

Aehr Test Systems (NASDAQ: AEHR) is a semiconductor test equipment company headquartered in Fremont, California, that manufactures wafer-level burn-in and reliability testing systems for silicon carbide (SiC) and gallium nitride (GaN) power device manufacturers.

Founded in 1977, AEHR is led by CEO Gayn Erickson and trades on the NASDAQ Small Cap Market tier, which carries lower minimum financial thresholds than the NASDAQ Global Select Market and typically attracts less institutional analyst coverage. As of June 2025, AEHR's market capitalization sits in the $200M–$300M range, classifying it firmly as a small-cap stock.

AEHR generates revenue through two streams. The first is capital equipment sales: its flagship FOX-NP (Full Wafer Contact, Non-Packaged) system, a test platform that contacts every die on a semiconductor wafer simultaneously and applies electrical stress and temperature to screen for early-life defects. Each FOX-NP system represents a significant capital expenditure (capex) purchase for customers, in the $500,000 to $2M+ range per unit. The system is modular, meaning customers can expand their testing capacity by adding WaferPak slots as production volumes grow.

The second revenue stream is consumables. The WaferPak contactor is a proprietary full-wafer contact interface that sits between the FOX system and the wafer, making electrical contact with every die simultaneously. WaferPaks wear out after a set number of uses and must be replaced, creating a recurring revenue line on top of capital equipment sales. Even when FOX system orders slow down, customers who already own installed systems continue purchasing WaferPak replacements. This consumable model provides a partial revenue floor during capital spending downturns and typically carries higher gross margins than system sales due to proprietary lock-in.

AEHR's primary customers are SiC power semiconductor manufacturers, with ON Semiconductor (onsemi) being the most significant disclosed customer. The company also addresses the gallium nitride (GaN) market as a secondary growth vector. GaN devices, used in fast chargers, 5G base stations, and data center power supplies, also require burn-in reliability qualification, expanding AEHR's total addressable market beyond SiC.

Wide bandgap (WBG) semiconductors, the broader category encompassing both SiC and GaN, are projected to grow substantially through 2030 as EV adoption accelerates, according to Yole Développement's Power SiC 2024 Market Report. Every new SiC or GaN fab that comes online is a potential AEHR FOX system customer, which means AEHR's addressable market scales with the broader energy transition.

The technology behind these products is what creates AEHR's competitive position, and understanding it is essential for evaluating the 2026 investment case.

How Aehr Test Systems Works: The Wafer-Level Advantage

Burn-in testing is the process of stressing semiconductor devices at elevated voltage and temperature before they ship, deliberately accelerating the failure mechanisms that cause early-life defects, so that only devices that survive the stress reach customers.

Think of it like stress-testing a bridge before it opens to traffic. Engineers apply loads far above normal operating conditions to expose weak points before lives depend on the structure holding. Burn-in testing does the same for chips: force the weak ones to fail in the controlled environment of the test lab rather than in the field, where failures are expensive, disruptive, or in the case of safety-critical automotive applications, dangerous.

The "bathtub curve" is the reliability model underlying burn-in. Semiconductor devices are most likely to fail either early in life (the infant mortality region, caused by latent manufacturing defects) or late in life (the wear-out region, caused by aging). Burn-in targets the infant mortality region by accelerating these early failures before shipment.

What separates AEHR from traditional burn-in approaches is where in the manufacturing process the testing occurs. Conventional burn-in tests chips after they have been individually packaged, which means defective chips have already absorbed the cost of packaging before they are identified and discarded. AEHR tests chips while they are still on the wafer, before dicing and packaging. A single wafer contains hundreds to thousands of individual dies, and AEHR's FOX-NP system contacts all of them simultaneously. Defective dies are identified at the cheapest possible point in the process, before the costly packaging step has been paid for.

SiC power devices require this approach more than conventional silicon chips do. SiC has higher latent defect rates than mature silicon technology, and the applications it serves, specifically EV powertrain inverters (the traction inverter converts DC battery power to AC for the electric motor, consuming 12–48 SiC MOSFETs per vehicle depending on architecture), are safety-critical. A SiC power device failure in an EV inverter is not a minor inconvenience. This makes burn-in screening non-negotiable for automotive-grade SiC, and automotive SiC manufacturers must complete AEC-Q101 reliability qualification before deploying devices in customer vehicles.

AEHR's competitive moat comes from three sources. Its proprietary WaferPak full-wafer contact interface cannot be easily replicated by competitors. Customers who have already qualified AEHR systems in their AEC-Q101 process face significant switching costs because re-qualifying an alternative system is expensive and time-consuming. And because AEHR focuses exclusively on this niche while larger test equipment companies address broader markets, it has maintained first-mover depth in SiC wafer-level burn-in that larger rivals have not matched.

The next section examines what happened to AEHR's stock and whether the thesis that supported its 2021–2023 run remains intact.

AEHR Stock Price History: From $3 to $53 and Back

AEHR reached an all-time high of approximately $53 per share in mid-2023, driven by investor conviction that silicon carbide semiconductors would power the EV revolution. That thesis was correct in its direction but arrived ahead of the actual demand cycle.

From a trough near $3 in early 2021, AEHR climbed steadily as SiC manufacturers, led by ON Semiconductor, placed large FOX system orders to expand their wafer-level burn-in capacity in anticipation of surging EV production. Revenue grew sharply through FY2022 and FY2023, and the stock reflected the market's excitement about SiC's role in the energy transition. Then the reversal began.

Why Did AEHR Stock Drop So Much?

AEHR stock dropped because silicon carbide manufacturers, its primary customers, slashed their capital expenditure budgets after EV demand growth stalled and SiC device inventory built up faster than end markets could absorb. The causal chain ran as follows:

1. AEHR's 2021–2023 run was driven by SiC investment optimism; revenue surged as ON Semiconductor and other SiC fabs placed large FOX system orders to build out wafer-level burn-in capacity.
2. EV demand growth decelerated significantly in 2023–2024 in the US and European markets, where early-adopter saturation set in and Chinese OEM price competition intensified.
3. SiC manufacturers accumulated inventory overhang: they had built out device stockpiles in anticipation of EV volumes that did not materialize at the projected pace.
4. ON Semiconductor and other SiC fabs responded by cutting their SiC expansion capex guidance, deferring new fab investments and equipment purchases.
5. AEHR's order book collapsed because SiC fab capex is AEHR's revenue. No capacity expansion means no new FOX system orders.
6. With high customer concentration and no alternative revenue source at sufficient scale, AEHR's revenue fell sharply, the company returned to operating losses, and the stock corrected more than 80% from its all-time high.

This is the semiconductor capital equipment cycle at work. Equipment makers like AEHR sit one layer downstream from chip demand: first SiC device demand must recover, then SiC manufacturers must decide to invest in new capacity, then they buy equipment. AEHR is a second-order derivative of the EV market, which means both the upswings and the downswings in its revenue are amplified relative to the underlying end market. Our analysis treats the current decline as primarily cyclical rather than structural. The technology is still required, the customers still exist, and the addressable market is still growing. What changed is timing.

As of June 2025, AEHR trades in the $5–$8 range, representing a decline of approximately 85–90% from its mid-2023 peak. That price history illustrates both the asymmetric upside potential and the brutal downside risk of owning a capital equipment company with concentrated customer exposure.

Understanding the decline requires understanding the SiC market that drives AEHR's order flow, which the next section covers in full.

Silicon Carbide and the EV Market: Why SiC Is Everything for AEHR

AEHR's revenue is a direct derivative of one variable: how much silicon carbide semiconductor manufacturers invest in new production capacity. That variable is, in turn, driven by EV demand.

What Is Silicon Carbide Used for in EVs?

Silicon carbide (SiC) is a wide bandgap semiconductor material used primarily in the power conversion systems of electric vehicles, where its ability to operate at higher temperatures and switching frequencies than conventional silicon enables longer driving range and faster charging.

In an EV powertrain, SiC MOSFETs are used in three main applications: the main traction inverter (which converts DC battery power to AC for the electric motor), the onboard charger (which converts AC grid power to DC for the battery), and the DC-DC converter. The traction inverter is the highest-value application, consuming 12–48 SiC MOSFETs per vehicle depending on voltage architecture. The shift from 400V to 800V powertrain architectures, already deployed in vehicles like the Porsche Taycan and Hyundai Ioniq 5, strongly favors SiC over silicon because SiC handles higher voltages more efficiently. This means SiC content per vehicle is increasing even when overall EV unit volume growth is modest.

Every SiC wafer produced by a semiconductor manufacturer must pass through reliability qualification before its devices can be deployed in automotive applications. AEHR's FOX system is the instrument performing the wafer-level burn-in component of that qualification. More SiC production equals more demand for AEHR's burn-in capacity. The causal chain is direct: EV production growth drives SiC demand, SiC demand drives SiC fab capex, and SiC fab capex drives AEHR's order intake.

The SiC market's three largest producers are ON Semiconductor (onsemi, NASDAQ: ON), Wolfspeed (NYSE: WOLF), and STMicroelectronics (NYSE: STM). Each has faced headwinds in 2024–2025. Wolfspeed, the world's largest pure-play SiC manufacturer, announced significant capex reductions and faces financial pressure from slower-than-expected demand. STMicroelectronics, a leading SiC MOSFET supplier to European automotive OEMs, also deferred expansion investments. These sector-wide signals confirm that AEHR's downturn reflects broad SiC market conditions rather than company-specific failures.

Is the SiC Semiconductor Market Recovering?

As of June 2025, the SiC semiconductor market shows early signs of inventory normalization, with the pace and timing of full capex recovery remaining uncertain but pointing toward a potential inflection in late 2025 or early 2026.

The downturn was caused by a double compression: EV demand growth in 2023–2024 came in below aggressive forecasts set during the 2021–2022 optimism cycle, while SiC manufacturers had over-ordered in anticipation of that growth. The result was an inventory correction that forced production cuts and capex deferrals across the sector.

Recovery signals to watch include ON Semiconductor's SiC revenue guidance in its quarterly earnings calls (any inflection from declining to stable to growing SiC revenue at ON Semi is a leading indicator for AEHR), Wolfspeed's capacity utilization rate (higher utilization signals recovering demand for SiC capacity), and automotive OEM announcements about 800V platform rollouts (more 800V vehicles mean more SiC content per vehicle, supporting volume recovery even at modest unit growth rates).

According to Yole Développement's Power SiC 2024 Market Report, the SiC power semiconductor market is projected to recover and resume growth through 2028–2030, driven by EV adoption and industrial power applications. The IEA's Global EV Outlook 2024 projects global EV sales to continue expanding, though at a more moderate pace than the 2021–2023 peak forecasts suggested. Even with moderate EV unit growth, increasing 800V adoption and SiC content per vehicle supports a recovery in SiC device demand.

For AEHR specifically, if SiC fab capex begins to inflect in H2 2025, order intake at AEHR could improve meaningfully by Q1–Q2 2026. The key uncertainty is not whether SiC will recover, but when, and how much of that recovery translates to new FOX system orders versus WaferPak consumable sales from the existing installed base.

AEHR's financial position shows exactly how deep the downturn ran and what recovery would need to look like numerically.

AEHR Financial Fundamentals: Revenue and Margins During the Downturn

AEHR achieved GAAP profitability in FY2023, the first sustained profitable year in its recent history, before returning to operating losses in FY2024 and FY2025 as the SiC demand cycle turned down.

The table below summarizes AEHR's key financial metrics from FY2023 through estimated FY2025, providing the foundation for the 2026 price scenarios discussed in the following section.

Sources: AEHR Test Systems 10-K and 10-Q filings via AEHR SEC EDGAR; StockAnalysis.com, Yahoo Finance; analyst consensus estimates. FY = fiscal year ending May 31. A = actual, E = estimate.

The P/S ratio (market capitalization divided by trailing 12-month revenue) is the most appropriate primary valuation metric for AEHR during this period because the company is operating at a net loss, making the price-to-earnings ratio non-meaningful. During the 2023 peak, AEHR commanded a P/S above 10x, reflecting the market's growth premium for what looked like a structurally expanding business. At current depressed revenue levels, the P/S appears compressed in absolute terms but is not necessarily cheap on a normalized basis, since the denominator itself has shrunk dramatically.

AEHR's gross margin historically runs between 40–55%, reflecting the proprietary nature of its products and the favorable WaferPak consumable mix. During the current downturn, gross margins have compressed toward 30–38% as fixed manufacturing costs spread over lower revenues. When revenue recovers, gross margin should expand back toward historical norms, and that fixed-cost structure creates earnings recovery potential significantly larger than the revenue recovery alone would suggest. This is one of the strongest bull-case arguments for AEHR's business quality.

CEO Gayn Erickson has consistently communicated in earnings calls that the company sees a recovery pipeline building, though management has been careful not to provide specific timing for a return to FY2023 revenue levels. Any forward-looking commentary from AEHR management about FY2026 order visibility will be among the most important data points for investors to track.

Institutional ownership data from Fintel and WhaleWisdom 13F filings as of early 2025 shows that institutional holders retain meaningful positions in AEHR despite the downturn, suggesting that at least some professional investors view the current price level as worth holding through the cyclical trough.

The customer concentration that drove this revenue collapse deserves its own analysis before examining what recovery could look like.

AEHR's Customer Concentration Risk: The ON Semiconductor Problem

Customer concentration risk is the most material ongoing investment risk in AEHR. The company has historically derived more than half of its revenue from one to three customers, with ON Semiconductor (onsemi, NASDAQ: ON) being the most significant.

Customer concentration risk is a financial term describing the danger that arises when a company generates a disproportionate share of revenue from a small number of customers, making total revenue highly sensitive to the purchasing decisions of any single customer. AEHR's 10-K filings with the SEC have disclosed that in peak demand periods, one to three customers have accounted for more than 50% of total revenue. This is common for capital equipment companies serving narrow technology markets, but AEHR's concentration level is materially elevated relative to larger peers like Teradyne (NASDAQ: TER).

ON Semiconductor (onsemi) is a major global SiC power device manufacturer with a large and growing SiC portfolio targeting EV and industrial markets. ON Semi's SiC capex decisions have a direct, outsized impact on AEHR's revenue because they determine how many FOX systems and WaferPak contactors AEHR ships in any given period.

The inventory correction narrative runs as follows. Beginning in 2023, ON Semi observed that its SiC device customers, primarily EV manufacturers, were not absorbing inventory at the pace originally forecasted. Rather than build further SiC device stockpiles, ON Semi significantly reduced its SiC expansion capex guidance across 2023 and 2024. This was not a sign that ON Semi was abandoning SiC. It was a rational response to an inventory overhang. But for AEHR, the effect was severe: without new SiC capacity expansion at its largest customer, AEHR's order book collapsed.

The diversification question is central to the 2026 thesis. AEHR has publicly indicated it is pursuing new SiC customers globally, including Asian SiC manufacturers and European tier-1 automotive suppliers. The company has also referenced interest from GaN device manufacturers. However, AEHR's customer non-disclosure agreements limit how specifically it can name new wins in public communications. Investors must evaluate diversification progress primarily through revenue trends and any management commentary about customer count rather than through named customer announcements.

Risk rating: HIGH. If ON Semiconductor does not resume meaningful SiC capex expansion in 2025–2026, AEHR's revenue recovery will be delayed regardless of broader SiC market conditions. AEHR's 2026 bear case assumes ON Semi remains cautious and no new customers of sufficient scale emerge. The bull case requires meaningful new customer additions that reduce the top-one-to-three customer concentration below 40% of revenue.

The analyst community's current view of AEHR's value adds another reference point for evaluating this risk against the potential upside.

AEHR Analyst Ratings and Price Targets

As of June 2025, a small number of analysts cover AEHR, reflecting the limited institutional research footprint typical of NASDAQ Small Cap Market companies. Low analyst coverage is itself a data point: it signals that AEHR remains under the radar for most institutional investors, which can mean both limited downside pressure from institutional selling and limited upside catalyst from analyst upgrades.

The table below shows available analyst ratings and price targets as of June 2025. Investors should verify current ratings at TipRanks AEHR analyst ratings before making investment decisions.

Source: TipRanks and MarketBeat. Data retrieved June 2025. Verify current ratings before investment decisions.

The analyst consensus price target for AEHR as of June 2025 sits approximately in the $11–$12 range, representing potential upside of 40–100% from a mid-range current price of approximately $6–$7. This consensus reflects moderate bullish conviction: analysts covering AEHR generally believe the SiC recovery thesis is intact, but they are not projecting a return to 2023 peak valuations.

Management guidance should be distinguished from analyst consensus. CEO Gayn Erickson's commentary in recent earnings calls has focused on order pipeline visibility improving compared to the trough of 2024, though AEHR has not provided specific FY2026 revenue guidance as of this writing. Any guidance upgrade from management on order intake would likely function as a near-term price catalyst.

AEHR has historically carried elevated short interest, a factor that amplifies the stock's volatility in both directions. Short interest (the percentage of AEHR's publicly traded float that has been sold short by investors betting the stock will decline) has at various points exceeded 15–25% of float, according to FINRA bi-monthly reporting data. The bear case interpretation is that well-informed institutional traders have examined AEHR and concluded the downside outweighs the upside. The bull case interpretation is that any positive catalyst, such as a large new customer announcement or better-than-expected quarterly revenue, could trigger a short squeeze, amplifying upside beyond what fundamental fair value alone would suggest. Both interpretations deserve weight. High short interest is not inherently bullish or bearish; it signals elevated conviction on both sides of the trade.

The scenario analysis that follows builds on this analyst consensus and financial context.

AEHR Stock Forecast 2026: Scenario-Based Price Analysis

Our base case Aehr Test Systems stock price target for 2026 is approximately $12–$15 per share, assuming SiC demand recovery begins normalizing in H2 2025, partial ON Semiconductor capex resumption occurs, and the market re-rates AEHR to a 3–4x price-to-sales (P/S) multiple on projected FY2026 revenue of approximately $60–$70M.

These scenarios are constructed by estimating revenue under different recovery assumptions, applying a P/S multiple consistent with the scenario's risk profile, and deriving an implied share price. This methodology is transparent and checkable: if you disagree with any assumption, you can substitute your own estimate. For context on how scenario-based price frameworks apply across different stock types, our MSTR stock price prediction using scenario methodology illustrates how the same analytical approach works for assets with different volatility profiles.

As of June 2025, AEHR's revenue run rate is approximately $25–$35M annualized, with the stock trading near a current P/S of 7–10x on that depressed revenue base. The 2026 scenarios project from this baseline.

The table below summarizes three scenarios for the Aehr Test Systems stock price prediction for 2026. All figures are analytical estimates based on stated assumptions and are not guarantees of future performance.

Methodology: Revenue estimate applied against a scenario-consistent P/S multiple produces implied market cap; divide by share count for implied price. All estimates are editorial scenario analysis, not financial advice. Source methodology derived from AEHR historical financial data via SEC EDGAR and StockAnalysis.com.

Bear Case: The bear case is not a prediction that AEHR will fail as a business. It describes a scenario where SiC market recovery takes longer than the base case timeline. If ON Semiconductor's next several earnings calls continue to show flat or declining SiC revenue guidance, and if AEHR does not announce new customers of meaningful scale, then FY2026 revenue could remain in the $30–$40M range. At a 2–3x P/S multiple consistent with a business facing ongoing uncertainty, the stock could stay in the $4–$7 range or decline further from current levels. Investors who buy today and hold through a prolonged bear case scenario would face additional losses from an already-depressed base.

Base Case: The base case assumes the SiC inventory correction has run its course by the time this article publishes, with recovery order flow beginning to appear in AEHR's quarterly results by Q1–Q2 2026. This would push FY2026 revenue toward $60–$70M, still well below FY2023's $79M peak but representing meaningful improvement from the trough. At a 3–4x P/S multiple, which is a conservative application of the recovery premium given AEHR's concentrated customer base, the implied share price is $12–$15. This represents 70–150% upside from current levels, which is the core of the speculative buy thesis.

Bull Case: The bull case requires both a faster-than-expected SiC demand recovery and meaningful customer diversification. If ON Semi resumes full SiC expansion capex and AEHR wins two or more new customers of sufficient order scale, FY2026 revenue could approach $90–$110M. At a 4–6x P/S multiple reflecting the market's willingness to re-rate AEHR toward its growth premium, the implied share price is $20–$30. Recovering to the $53 all-time high is not part of any realistic 2026 scenario under our analysis; it would require a P/S re-rating and revenue scale that current data does not support.

Investors comparing industrial equipment recovery theses may find our CAT stock 2026 price target analysis useful for understanding how cyclical equipment companies re-rate during demand recoveries.

The Bull Case: What Would Drive AEHR's Recovery?

AEHR's bull case for 2026 rests on a specific sequence of conditions materializing, not on broader market sentiment or speculative re-rating.

The conditions, and their implications if they occur:

1. If ON Semiconductor resumes SiC capex expansion, then AEHR's order intake inflects. ON Semi's SiC revenue growing sequentially in two or more consecutive quarters would be the clearest leading indicator that SiC fab investment is resuming, and that AEHR FOX system orders are coming.

2. If AEHR announces new SiC customer wins, then customer concentration risk decreases. A publicly disclosed new customer from Asia or Europe with meaningful initial order volume would change the risk profile of the 2026 base case by reducing single-customer dependency. Even without a named announcement, management commentary about "multiple customers" contributing to order pipeline would signal diversification progress.

3. If gross margins recover toward 45–50%, then the fixed-cost structure amplifies earnings recovery. AEHR's cost base means that incremental revenue at higher gross margins flows through to operating income at an accelerating rate. A return to $60–$70M in revenue at 45–50% gross margins would likely restore GAAP profitability, which itself is a catalyst for P/S re-rating.

4. If short sellers cover positions on positive catalysts, then short squeeze dynamics could amplify stock appreciation beyond fundamental fair value for a period. This is not a thesis to build a long position on, but it means positive news flow at AEHR may produce price moves larger than the fundamental change in value would suggest.

5. If 800V EV architecture adoption accelerates, then SiC content per vehicle increases and supports volume recovery even at moderate EV unit sales growth. The EV industry's broader shift to 800V platforms is a structural tailwind for SiC demand that reduces AEHR's dependence on raw EV unit volume growth.

The WaferPak installed base provides an additional floor: customers who already own FOX systems continue purchasing WaferPak contactors for their existing production lines. This consumable revenue stream acts as a picks-and-shovels anchor, giving AEHR some revenue continuity even when capital equipment orders are slow.

EV manufacturer production volumes remain the upstream driver of SiC demand. For context on how one major EV manufacturer's production trajectory connects to the broader SiC demand chain, our Rivian stock price prediction and scenario analysis examines the EV production thesis from a different angle.

Recovery signals are building, but the bear case risks deserve equal analytical weight.

The Bear Case: What Are the Risks of Investing in AEHR?

Six material risks could prevent AEHR from recovering in 2026, and investors evaluating a position should weigh each one against their conviction in the SiC recovery thesis.

1. Customer Concentration Risk: HIGH probability of impact if ON Semi defers further

AEHR has historically derived more than 50% of revenue from one to three customers. If ON Semiconductor continues to defer SiC capex expansion through 2026, AEHR has no other customer base at sufficient scale to compensate. The revenue cliff this creates is not a theoretical concern; it already happened in 2024. This risk is the single most important factor separating the bear case from the base case.

2. SiC Recovery Timing Uncertainty: HIGH probability of uncertainty

The SiC market is recovering, but "recovering" does not mean recovered. If inventory normalization takes until late 2026 or 2027, AEHR's order intake recovery could push into periods beyond the investment horizon considered here. SiC fab managers have limited forward visibility into their own customers' EV production schedules, which makes capex timing genuinely difficult to forecast.

3. Small-Cap Liquidity Risk: MEDIUM

AEHR's NASDAQ Small Cap Market listing means lower daily trading volume, wider bid-ask spreads, and less institutional market-making than larger stocks. During periods of negative news or broad market risk-off, small-cap stocks can fall faster than their fundamental deterioration warrants. Investors with large position sizes relative to AEHR's average daily volume may find exits difficult without moving the price.

4. Competition Risk: MEDIUM

Teradyne (NASDAQ: TER) and Advantest, two large semiconductor test equipment companies, have the engineering resources and customer relationships to develop competing wafer-level burn-in solutions if the SiC market grows large enough to justify the investment. Some SiC manufacturers may also pursue proprietary in-house testing solutions to reduce equipment vendor dependency. Neither threat is immediate, but both are real over a multi-year horizon.

5. Technology Obsolescence Risk: LOW-MEDIUM

Alternative reliability screening approaches, including inline process monitoring improvements and advances in package-level testing efficiency, could reduce the commercial necessity of wafer-level burn-in over a 5–10 year horizon. This is not a 2026 risk, but long-term investors should monitor whether alternative screening methods are gaining traction in SiC fab qualification processes.

6. Macro and Policy Risk: MEDIUM

Broader semiconductor capex cycles, EV incentive policy changes such as modifications to the US Inflation Reduction Act's EV tax credits, and continued Chinese EV market dominance reducing Western OEM profitability and capex appetite all represent external risks that could delay SiC recovery independent of AEHR's specific competitive position.

High short interest in AEHR signals that well-informed traders have examined these risks and reached a bearish conclusion with real capital behind it. Investors should not dismiss this signal. The short interest community may be pricing in risks that the bull thesis underestimates.

These risks are manageable if the SiC recovery materializes on the base case timeline, but they set the conditions under which the bear case becomes the more likely outcome.

How Does AEHR Compare to Teradyne and Cohu? Peer Valuation Analysis

AEHR trades at a compressed P/S multiple relative to its 2023 peak, and the question for 2026 investors is whether that compression represents an entry opportunity or a fair reflection of persistent revenue uncertainty.

The table below compares AEHR to Teradyne (NASDAQ: TER) and Cohu (NASDAQ: COHU), its primary semiconductor test equipment peers, on key valuation and financial metrics as of June 2025.

Source: StockAnalysis.com, Yahoo Finance, June 2025. Verify current figures before investment decisions. All data subject to quarterly earnings updates.

Teradyne designs and manufactures automatic test equipment (ATE) for semiconductors, electronics, and industrial automation. At approximately $18B in market capitalization, TER operates in a different league from AEHR. TER does not directly compete in AEHR's wafer-level burn-in niche; it focuses on functional test rather than reliability screening. TER is the most useful valuation benchmark because it represents what the market pays for a high-quality, lower-risk semiconductor test equipment business. For context on TER's own 2026 investment case, our Teradyne stock 2026 price target analysis provides a parallel framework.

Cohu (NASDAQ: COHU) makes semiconductor test handlers and contactors, along with related interface products, a more directly comparable niche to AEHR's position. Cohu also faces cyclical semiconductor capex headwinds and trades at a much lower P/S than AEHR due to its larger revenue base, making it a useful sector context comparison.

The valuation picture that emerges from this comparison is nuanced. AEHR's current P/S of 7–9x on highly depressed revenue appears elevated in absolute terms compared to Cohu's 1–1.5x. But AEHR's revenue base has been compressed by the SiC downturn. If FY2026 revenue recovers to $60–$70M under the base case, the current market cap implies a forward P/S of approximately 3–4x, which sits at a reasonable recovery premium relative to Cohu and a modest discount to Teradyne. At current prices, AEHR appears conditionally undervalued if revenue recovers to base case levels by 2026, but could remain fairly valued or even overvalued if recovery is delayed significantly.

For investors considering AEHR within the broader SiC investment universe, the alternatives include Wolfspeed (NYSE: WOLF), ON Semiconductor (NASDAQ: ON), and STMicroelectronics (NYSE: STM) as direct SiC device manufacturers. AEHR's differentiation is that it provides testing equipment to all SiC manufacturers rather than betting on which device manufacturer wins market share. This positions it as a picks-and-shovels play on the SiC sector rather than a bet on any single producer's success.

Our Verdict: Is AEHR Stock a Buy in 2026?

VERDICT: Speculative Buy Investment horizon: 12–24 months Confidence level: Moderate. Conditional on SiC demand normalization beginning in H2 2025. Thesis: AEHR's wafer-level burn-in technology remains necessary for SiC manufacturers. The revenue collapse is cyclical. At base case 2026 revenue recovery, the current price represents meaningful upside.

Note: This analysis is for informational purposes only and does not constitute personalized investment advice. See full disclaimer below.

Three factors support the speculative buy verdict:

1. The SiC market recovery appears to be forming, though timing remains uncertain. Inventory normalization across the sector is progressing. ON Semiconductor's most recent earnings commentary has shown SiC revenue stabilizing rather than continuing to decline. The IEA and BloombergNEF both project continued EV growth through 2026, with 800V architecture adoption increasing SiC content per vehicle even at moderate unit growth. A recovery that began before this article's publication date is already building toward the conditions the base case requires.

2. The current valuation prices in an extended depression that may not materialize. At $5–$8 per share, AEHR's market capitalization is approximately $200–$280M. If FY2026 revenue recovers to the base case range of $60–$70M, that implies a forward P/S of 3–4x, which is lower than AEHR's historical growth-premium valuation and sits at a plausible recovery multiple for a capital equipment company with a defensible technology niche. The current price does not require recovery to the 2023 peak to generate positive returns.

3. Analyst consensus points toward upside. The three analysts currently covering AEHR have a consensus price target of approximately $11–$12, representing 60–100% upside from June 2025 price levels. While AEHR's limited analyst coverage means this consensus carries less weight than a widely covered stock, the direction and magnitude of analyst targets is consistent with the base case scenario analysis.

Two conditions that would change the verdict:

• Verdict would shift to Avoid if: ON Semiconductor reports flat or declining SiC capex for a third consecutive quarter with no new AEHR customer announcements through Q3 2025. This would signal the bear case timeline is materializing and the base case recovery may not arrive in 2026.
• Verdict would upgrade to Buy if: AEHR announces two or more new SiC customers of meaningful revenue scale, reducing the top customer concentration to below 40% of projected revenue. Customer diversification is the structural improvement that transforms a speculative recovery thesis into a higher-confidence investment.

AEHR may be appropriate for investors with high risk tolerance and a 12–24 month horizon who are comfortable with small-cap liquidity risk and single-customer revenue concentration. It is not appropriate for capital-preservation-focused or income-seeking investors.

Traders who want to access AEHR price movements via Bybit's crypto derivatives platform can view the AEHRUSDT perpetual contract on Bybit. For a step-by-step guide to trading the AEHRUSDT perpetual, see How to Trade AEHRUSDT: The Complete Step-by-Step Guide.

Investment Disclaimer

This article is for informational and educational purposes only. It does not constitute personalized investment advice, a recommendation to buy or sell any security, or an offer or solicitation to purchase or sell any security. All investment involves risk, including the possible loss of principal. Past performance does not guarantee future results. The financial information in this article is believed to be accurate as of the publication date noted above but is subject to change without notice. Price forecasts and scenarios presented in this article are analytical estimates based on publicly available information and are not guarantees of future performance. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decisions. The author and publisher may hold positions in securities mentioned in this article. Please see the author disclosure below.

Frequently Asked Questions About AEHR Stock

What is AEHRUSDT?

AEHRUSDT is not a cryptocurrency trading pair. The USDT suffix comes from Tether, a USD-pegged stablecoin, and is used in crypto exchange trading pair notation. Some charting platforms display equity ticker symbols alongside crypto pairs using this format, which is likely where the search term originates. AEHR is a NASDAQ-listed stock, specifically Aehr Test Systems (NASDAQ: AEHR), not a crypto token. For a full explanation of the AEHRUSDT instrument on Bybit, see What Is AEHRUSDT? Aehr Test Systems Crypto Trading Pair Explained.

Is AEHR a stock or a cryptocurrency?

AEHR is a stock. Aehr Test Systems (NASDAQ: AEHR) is a publicly traded US semiconductor equipment company listed on the NASDAQ stock exchange. It is not a cryptocurrency, token, or blockchain-based asset. You purchase AEHR shares through a traditional brokerage account, not through a crypto exchange.

Should I buy AEHR stock in 2026?

Whether AEHR suits your portfolio depends on your risk tolerance, investment horizon, and comfort with speculative small-cap positions. Investors with high risk tolerance and a 12–24 month horizon may find AEHR compelling if the SiC semiconductor market recovery materializes as projected in the base case. Investors seeking capital preservation, income, or lower volatility should avoid it. This is not personalized investment advice. See the full disclaimer above.

Will AEHR stock recover to its all-time high of $53?

Recovering to $53 in 2026 falls outside both our base case and bull case scenarios. That price level requires a P/S multiple and revenue trajectory that would demand both a full SiC market recovery and re-rating to peak-cycle valuation premiums simultaneously. Our bull case projects a more modest $20–$30 price range under highly favorable conditions. The $53 all-time high is useful context for understanding the scale of the drawdown, not a realistic near-term price target.

How can I buy AEHR stock?

To buy AEHR stock: (1) Open a brokerage account with a major US broker such as Fidelity, Charles Schwab, TD Ameritrade, Robinhood, or Interactive Brokers. (2) Search for the ticker symbol AEHR. (3) Place a market or limit order for the number of shares you want to purchase. AEHR trades on the NASDAQ exchange during regular US market hours and is not available as actual shares on cryptocurrency exchanges.

Does AEHR pay a dividend?

As of June 2025, Aehr Test Systems does not pay a dividend. The company retains earnings for reinvestment in its operations and research and development. Investors seeking income from dividends should note this before initiating a position.

What is AEHR's competitive advantage?

AEHR's competitive advantage rests on its proprietary WaferPak full-wafer contact technology, which competitors cannot easily replicate; first-mover positioning in SiC wafer-level burn-in, giving it an installed base and customer qualification history that create switching costs; and consumable lock-in, as customers who standardize on FOX systems must continue purchasing WaferPak replacements. These advantages are real but not impenetrable if larger test equipment companies decide the market justifies entry.

Is AEHR's stock decline permanent or cyclical?

Our analysis treats the decline as primarily cyclical rather than structural. The core business model, wafer-level burn-in testing for SiC power devices, remains intact and the technology is still required by SiC manufacturers. The revenue collapse reflects a capex cycle downturn driven by EV demand deceleration and SiC inventory correction, not a fundamental loss of competitive position. Recovery depends on whether SiC manufacturers resume expansion capex in 2025–2026 and whether AEHR successfully diversifies beyond its top customer.

Related Reading

• Aehr Test Systems Stock Price Today: Live AEHRUSDT Data
• AEHR Stock Forecast 2026: Analyst Price Targets
• What Is AEHRUSDT? Aehr Test Systems Crypto Trading Pair Explained
• How to Trade AEHRUSDT: The Complete Step-by-Step Guide
• Rivian (RIVN) Stock Price Prediction 2030: Scenario Analysis
• CAT Stock Prediction 2026: Price Targets for Cyclical Recovery
• MSTR Stock Price Prediction 2030: Scenario Framework
• Teradyne Stock 2026: Price Targets for Semiconductor Equipment

Author: Financial Analysis Team, equity research specialists with experience covering semiconductor capital equipment and clean energy investment themes. The author does not hold a position in AEHR or related securities as of the publication date. This content is produced for informational purposes only and does not constitute personalized investment advice.